Preoperative hyponatremia is associated with postoperative major morbidity, prolonged length of stay, non-home discharge, and readmission in total shoulder arthroplasty

2020 ◽  
Vol 30 (2) ◽  
pp. 162-168
Author(s):  
Richard C. Lee ◽  
Matthew V. Abola ◽  
Jerry Y. Du ◽  
Joseph E. Tanenbaum ◽  
Lakshmanan Sivasundaram ◽  
...  
2016 ◽  
Vol 25 (2) ◽  
pp. 193-200 ◽  
Author(s):  
Grant H. Garcia ◽  
Michael C. Fu ◽  
David M. Dines ◽  
Edward V. Craig ◽  
Lawrence V. Gulotta

2019 ◽  
Vol 28 (10) ◽  
pp. 1854-1860 ◽  
Author(s):  
Sophia A. Traven ◽  
Kathy M. McGurk ◽  
Russell A. Reeves ◽  
Zeke J. Walton ◽  
Shane K. Woolf ◽  
...  

2015 ◽  
Vol 24 (5) ◽  
pp. 754-759 ◽  
Author(s):  
John C. Dunn ◽  
Joseph Lanzi ◽  
Nicholas Kusnezov ◽  
Julia Bader ◽  
Brian R. Waterman ◽  
...  

2021 ◽  
pp. 175857322110230
Author(s):  
McKayla Kelly ◽  
Justin Turcotte ◽  
M Brook Fowler ◽  
Michaline West ◽  
Cyrus Lashgari ◽  
...  

Background The purpose of this study is to evaluate the impact of intravenous tranexamic acid on clinical and hematologic outcomes after total shoulder arthroplasty. Methods Retrospective review was conducted for 282 consecutive patients undergoing either anatomic shoulder arthroplasty or reverse total shoulder arthroplasty. Univariate analysis and multivariate linear regression were used to compare outcomes for patients receiving intravenous tranexamic acid with those who did not. Results Of the 282 patients included in this study, 78 patients received intravenous tranexamic acid and 204 did not. Patients who received intravenous tranexamic acid had significantly lower pre- to postoperative change in hemoglobin and hematocrit, and decreased postoperative drain output. In addition, patients receiving intravenous tranexamic acid were significantly less likely to have a postoperative hematocrit <30. There were no significant differences in length of stay, rate of 30 day hematoma, surgical site infection, deep vein thrombosis, or readmission between groups. Conclusion Intravenous tranexamic acid is associated with a significant reduction in change in hematocrit and hemoglobin and postoperative drain output after both anatomic and reverse total shoulder arthroplasty. Despite improving hematologic outcomes for these patients, tranexamic acid appears to have little impact on clinical outcomes such as length of stay and 30-day complication rates.


Author(s):  
Cesar D. Lopez ◽  
Michael Constant ◽  
Matthew JJ. Anderson ◽  
Jamie E. Confino ◽  
John T. Heffernan ◽  
...  

2021 ◽  
pp. 175857322199382
Author(s):  
Brandon Amirian ◽  
Kyrillos M Akhnoukh ◽  
Asad M Ashraf ◽  
Samuel J Swiggett ◽  
Francis E Rosato ◽  
...  

Background Chronic obstructive pulmonary disease patients have been shown in orthopedic literature to have poorer outcomes and higher rates of complications from surgery. In this retrospective review, medical complications, length of stay, and costs were obtained to explore the effects of chronic obstructive pulmonary disease on patients undergoing primary total shoulder arthroplasty. Methods Total shoulder arthroplasty cases from January 2005 to March 2014 were queried and analyzed from a nationwide database. Study patients were matched 1:5 to controls by age, sex, and medical comorbidities associated with chronic obstructive pulmonary disease. In-hospital length of stay, 90-day medical complications, day of surgery, and total global 90-day episode of care costs were obtained for comparison. Results Chronic obstructive pulmonary disease patients were found to have higher incidence and odds (53.91 vs. 11.95%; OR: 3.58, 95%CI: 3.18–3.92, p < 0.0001) of 90-day medical complications, longer in-hospital length of stay (3 vs. 2 days, p < 0.0001), and significantly higher 90-day costs ($14,768.37 vs. $13,379.20, p < 0.0001) following primary total shoulder arthroplasty compared to matched controls. Discussion Chronic obstructive pulmonary disease patients undergoing primary total shoulder arthroplasty have higher rates of medical complications, in-hospital length of stay, and costs of care. This represents an important factor that will allow orthopedic surgeons to adequately manage expectations and educate chronic obstructive pulmonary disease patients of the potential complications which may occur following total shoulder arthroplasty.


2019 ◽  
Vol 233 ◽  
pp. 360-367 ◽  
Author(s):  
Daniel Burguete ◽  
Ali A. Mokdad ◽  
Mathew M. Augustine ◽  
Rebecca Minter ◽  
John C. Mansour ◽  
...  

2021 ◽  
pp. 175857322110273
Author(s):  
Puneet Gupta ◽  
Theodore Quan ◽  
Zachary R Zimmer

Background Octogenarians are at an increased risk of morbidity and mortality following various surgeries, but this has not yet been well explored in octogenarians undergoing revision total shoulder arthroplasty (RTSA). Thus, the purpose of this study was to analyze whether octogenarians undergoing RTSA are at an increased risk of 30-day postoperative complications, readmissions, and mortality relative to the younger geriatric population. Methods Data of patients who underwent RTSA from 2013 to 2018 were obtained from a large de-identified database. Patients were divided into two cohorts: ages 65–79 and ages 80–89. Demographic data, comorbidities, and postoperative complications were collected and compared between the two cohorts. Bivariate and multivariate analyses were performed. Results On bivariate analyses, patients aged 80–89 were more likely to develop pulmonary embolism (p = 0.014) and extended length of stay more than 3 days (p = 0.006) compared to the cohort aged 65–79. Following adjustment on multivariate analyses, 80–89 years old patients no longer had an increased likelihood of pulmonary embolism or extended length of stay compared to the 65–79 age group. Octogenarians were not found to have higher rates of 30-day readmissions (p = 0.782), mortality (p = 0.507), reoperation (p = 0.785), pneumonia (p = 0.417), urinary tract infection (p = 0.739), or sepsis (p = 0.464) compared to the cohort aged 65–79 following RTSA. Conclusion Age greater than 80 should not be used independently as a factor for evaluating whether a geriatric patient is a proper candidate for RTSA.


Sign in / Sign up

Export Citation Format

Share Document